Alcoholic Liver Disease

You might also like

Download as pptx, pdf, or txt
Download as pptx, pdf, or txt
You are on page 1of 27

ALCOHOLIC LIVER DISEASE

DR ALEX MOGERE.
CONSULTANT PHYSICIAN
Spectrum of alcoholic liver disease
1) Fatty liver/steatosis >90%

2) Alcoholic hepatitis 10-15%

3) Cirrhosis 10-20%

4) Hepatocellular carcinoma
Risk factors in development of Alcoholic
liver disease.
Quantity & duration of alcohol use
Genetics:
 Sex: Females more susceptible >males in
progression of liver disease
 Non gender linked genetic factors
 Metabolic traits
Diet & Obesity
Risk factors :Quantity & Duration
 Risk of development of ALD starts at 30gms/day of
ethanol
 But for most individuals the dose that confers
significant risk is >80gms/day
 Studies show that males consuming >160gms/day
for>8yrs developed cirrhosis
 Wine drinkers have lower risk >beer & spirit
drinkers
 Daily drinking worse effect >intermittent as the
latter gives liver opportunity to recover
Alcohol abuse vs dependence
• Alcohol abusers- drink despite recurrent
interpersonal, social or legal problems
• Dependence: presence of 3 or > of the following:
• Tolerance
• Withdrawal symptoms
• Loss of control over drinking
• Strong desire to drink
• Drinking despite harm
Detection of alcohol abuse
• CAGE(cut down, annoyed by criticism,Guilty
about drinking,Eye opener in the morning)
• AUDIT(alcohol use disorders identification
tests)-a 10 item questionnare
Alcohol metabolism

 Alcohol absorption occurs in duodenum &


jejunum
 Absorption rapid with empty stomach &
delayed with food
 Has 3 mjr pathways: alcohol dehydrogenases,
cytochrome P450 2E1, catalase
Alcohol metabolism
 80-85% of ethanol oxidation is by initial
conversion to acetaldehyde catabolised by
alcohol dehydrogenase(ADH)
 Acetaldehyde is further oxidized by
acetaldehyde dehydrogenase
 Both oxidation lead to ↑ ration of
NADH/NAD & this plays a major role in the
initial pathogenesis of alcohol induced fatty
liver
Pathogenesis
• Genetic factors(ADH2,ALDH2)
• Toxic metabolites of ALDH(adducts)
• Free radicals and oxidative stress
• Role of immune system
• Hypermetabolic state of hepatocyte
• Cytokines(TNF, TGF)
• malnutrition
Clinical features
 History of heavy alcohol consumption

 Vague abdominal complaints e.g RUQ discomfort

 Physical exam:
Hepatomegally +/-tender
Vascular spider +/-
Features of CLD +/-
Clinical features/Syndrome
Fatty liver:
Usually asymptomatic
+/-Tender smooth ,firm palpable liver

LFTs may be normal or have


↑GGT +
slightly ↑transaminase
Clinical features/Syndrome
Acute alcoholic hepatitis
Is a distinct clinical presentation characterized by
jaundice & liver failure in a patient with
prolonged & excessive alcohol consumption
Recent jaundice helps to distinguish with
decompensated cirrhosis
Encephalopathy,RF,Coagulopathy (based on PT) &
serum levels of bilirubin are independent
prognostic markers in AH
Alcoholic Hepatitis:
Diagnosis is based on history of alcohol abuse +
lab results + exclusion of other causes of Acute
liver Injury

Labs: Serum Bilirubin >85µmol/L,


AST>ALT, AST usually <400IU/ml
WBC >10,000/mm3 with an ↑PMN
Alcoholic hepatitis: some clinical manifestations
 Fatigue,anorexia,jaundice,RUQ pain
 Tender hepatomegally , +/-arterial bruit over liver
 +/-fever
 Florid vascular spider
 +/- Associated malnutrition/vit def.
 +/- associated liver failure e.g
ascites,encephalopathy,bleeding diathesis
Clinical features/Syndrome
Alcoholic liver cirrhosis
 H/O alcohol use
 Hepatomegally –nodular
 Extrahepatic features e.g. Dupuytrens
contracture(feature of alcohol rather than
cirrhosis),features of liver failure
 Splenomegally in portal hypertension
Evaluation
Liver biochemistry:
↑ AST>ALT
↑ GGT
↑ ALP : particularly those with cholestasis & alcohol related
hepatitis
↓ Albumin: Particularly in cirrhosis

Serum IgA +/-↑


Elevated levels of CDT(carbohydrate deficient Transferin)- is an
alcohol biomarker test
CDT can be used to test whether one is a binge drinker or a daily
heavy drinker.cane even check alcoholic relapse
Evaluation
Haematology
 ↑MCV

 Macrocytosis is presumed to be due to a direct


effect of alcohol on bone marrow.
Def of folate & vit. B12.can contribute in the
malnourished

 The combination of ↑MCV & ↑GGT will identify


90% of alcoholic dependent pts.
Evaluation
Imaging
 Abdominal ultrasound
Check for fatty change ,fibrosis, cirrhosis
 CT scan / MRI Scan: Shows fatty liver, cirrhosis

Liver biopsy:
 Rarely required to exclude other causes;
 Differentiates steatosis from steatohepatitis & alcoholic
hepatitis from cirrhosis
Treatment of ALD
General/universal issues:

 Stop alcohol: Watch for withdrawal symptoms


& treat.- vitamins, diazepam /
chlordiazepoxide
 Identify & treat psychological & physical issues
Treatment of ALD: Acute alcoholic hepatitis.

1) Corticosteroids:
 suppresses hepatic inflammatory response & most effective therapy
 However C/I in active sepsis & bleeding: If present treat then start
steroid
 Failure of drop of bilirubin level by day 7 is indicative of steroid non
responsive: these patients have poor prognosis.
 Increase albumin prdn
 Antifibrotic
 Improves caloric intake by increasing appetite
 32 mg p.o x 4/52 then taper
 Prednisolone preferred over prednisone
Ct .prednisolone
Ideal patient has:
• MDF > 32 with spont encephalopathy.

C/I:
• Active G/I bleeds,
• HRS
• Sepsis
• AVH
Pentoxyfilline
• Attenuates TNF a release and action
• Decreases blood viscousity
• Lower portal htn
• Antifibrogenic
• Improves organ microcirculation
• Tissue oxygenation
• 400mg tid x 4 weeks
Treatment of ALD: Acute alcoholic hepatitis

2) Pentoxifyillin:
Give in those in whom steroid is C/I
Improves survival in severe disease by 40%

3) Correct protein & calorie malnutrition


Treatment of ALD: Cirrhosis
 Give vitamins

 Treat complications

 Liver transplantation: Alcohol related liver


disease account for 20-30% of all indications
of liver transplantation in USA/UK
PROGNOSTIC SCORES FOR ALCOHOLIC
HEPATITIS
• Maddrey Discriminant Fxn (Modified DF):
4.6x(prolongation of PT)+bilirubin; <32 1
month mortality is 10%;> 32 1 month
mortality is 35%;
• Glasgow alcoholic hepatitis score (score > 9
poor prognosis)
• MELD
• CTP-child- Turcotte- pugh
END

You might also like